Over the last 10 years, the lysosome-mediated degradation pathway macroautophagy has gained prominence in the field of adult onset neurodegeneration. Macroautophagy is an essential cellular pathway responsible for the elimination of cytosolic proteins, lipids and organelles. It is the most conserved of the three forms of autophagy, and its importance in mammals can be seen in a wide array of processes from the earliest stages of development to the maintenance of the aging brain. Although neurons were among the earliest cell types to be examined for macroautophagy, subsequent biochemical and genetic studies in liver and yeast caused the interest in neuronal macroautophagy to wane. Nonetheless, as the importance of macroautophagy in neurodegenerative diseases continues to grow, it is clear that we must refocus our attention on neural macroautophagy if we are truly to understand how this essential pathway impacts the adult brain. In this proposal, we will examine two key questions that will define how fundamental macroautophagic events are relevant in the healthy and diseased adult brain.
In Aim 1, we will define how membrane cholesterol impacts macroautophagy, and how disruptions in cholesterol homeostasis may lead to dysfunctional autophagy in the mammalian brain. Then in Aim 2, we will determine if aggregation-prone proteins are indeed eliminated by macroautophagy in the adult brain, and establish the minimal components essential for this process. By answering these questions, we will not only further our mechanistic understanding of key macroautophagic processes, but we will also understand them in a context that will further our understanding of how macroautophagy can impact neurodegenerative disease.
To maintain a healthy neuron, disposal systems such as autophagy must be intact. In diseases of the aging brain, this pathway can play an important role to promote disease recovery. To identify how autophagy can help fight neurodegeneration, our proposal focuses on two key questions that will help determine therapeutic strategies to combat disease.
| Kauffman, Karlina J; Yu, Shenliang; Jin, Jiaxin et al. (2018) Delipidation of mammalian Atg8-family proteins by each of the four ATG4 proteases. Autophagy 14:992-1010 |
| Yu, Shenliang; Melia, Thomas J (2017) The coordination of membrane fission and fusion at the end of autophagosome maturation. Curr Opin Cell Biol 47:92-98 |
| Eenjes, Evelien; Dragich, Joanna M; Kampinga, Harm H et al. (2016) Distinguishing aggregate formation and aggregate clearance using cell-based assays. J Cell Sci 129:1260-70 |
| Dragich, Joanna M; Kuwajima, Takaaki; Hirose-Ikeda, Megumi et al. (2016) Autophagy linked FYVE (Alfy/WDFY3) is required for establishing neuronal connectivity in the mammalian brain. Elife 5: |
| Yang, X William; Yamamoto, Ai (2014) CLEARance wars: PolyQ strikes back. Nat Neurosci 17:1140-2 |
| Nath, Sangeeta; Dancourt, Julia; Shteyn, Vladimir et al. (2014) Lipidation of the LC3/GABARAP family of autophagy proteins relies on a membrane-curvature-sensing domain in Atg3. Nat Cell Biol 16:415-24 |
| Yamamoto, Ai; Yue, Zhenyu (2014) Autophagy and its normal and pathogenic states in the brain. Annu Rev Neurosci 37:55-78 |
| Shoji-Kawata, Sanae; Sumpter, Rhea; Leveno, Matthew et al. (2013) Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494:201-6 |
| Johnson, Christopher W; Melia, Thomas J; Yamamoto, Ai (2012) Modulating macroautophagy: a neuronal perspective. Future Med Chem 4:1715-31 |
| Choy, Augustine; Dancourt, Julia; Mugo, Brian et al. (2012) The Legionella effector RavZ inhibits host autophagy through irreversible Atg8 deconjugation. Science 338:1072-6 |
Showing the most recent 10 out of 15 publications
